CD117 (c-Kit) Is Expressed During CD8
CD117
T cells
apoptosis
c-kit
galectin-1
stem cell factor
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2019
2019
Historique:
received:
31
05
2018
accepted:
21
02
2019
entrez:
2
4
2019
pubmed:
2
4
2019
medline:
4
9
2020
Statut:
epublish
Résumé
CD117 (cKit) is the receptor for stem cell factor (SCF) and plays an important role in early haemopoiesis. We show that CD117 is also expressed following priming of mature human CD8
Identifiants
pubmed: 30930902
doi: 10.3389/fimmu.2019.00468
pmc: PMC6428734
doi:
Substances chimiques
Receptors, Antigen, T-Cell
0
KIT protein, human
EC 2.7.10.1
Proto-Oncogene Proteins c-kit
EC 2.7.10.1
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
468Subventions
Organisme : Medical Research Council
ID : MR/K021192/1
Pays : United Kingdom
Références
J Immunol. 2000 May 1;164(9):4783-9
pubmed: 10779785
Blood. 2001 Feb 15;97(4):1086-91
pubmed: 11159541
Nat Immunol. 2001 Aug;2(8):711-7
pubmed: 11477407
J Immunol. 2002 Dec 15;169(12):6842-9
pubmed: 12471116
J Immunol. 2003 Mar 1;170(5):2456-60
pubmed: 12594270
Lab Invest. 2003 Mar;83(3):377-86
pubmed: 12649338
J Immunol. 2003 Sep 15;171(6):2930-6
pubmed: 12960316
Angiogenesis. 1999;3(4):317-25
pubmed: 14517411
Blood. 2005 Jul 1;106(1):193-200
pubmed: 15746078
Blood. 2005 Dec 1;106(12):3898-906
pubmed: 16118316
J Exp Med. 2005 Nov 21;202(10):1349-61
pubmed: 16287711
Cancer Cell. 2006 Apr;9(4):287-300
pubmed: 16616334
Stat Appl Genet Mol Biol. 2004;3:Article3
pubmed: 16646809
Br J Dermatol. 2006 Jun;154(6):1094-9
pubmed: 16704639
J Clin Invest. 2006 Sep;116(9):2543-51
pubmed: 16932807
J Cutan Pathol. 2007 Jan;34(1):7-14
pubmed: 17214848
Int J Cancer. 2007 Jun 1;120(11):2331-8
pubmed: 17304502
J Exp Med. 2007 Jun 11;204(6):1257-65
pubmed: 17502665
J Exp Med. 2007 Dec 24;204(13):3077-84
pubmed: 18070933
Nat Med. 2008 May;14(5):565-73
pubmed: 18454155
J Invest Dermatol. 2012 Sep;132(9):2245-54
pubmed: 22622427
Physiol Rev. 2012 Oct;92(4):1619-49
pubmed: 23073628
Cancer Res. 2013 Feb 1;73(3):1107-17
pubmed: 23204230
Nat Immunol. 2013 Dec;14(12):1277-84
pubmed: 24185616
PLoS Pathog. 2015 Oct 20;11(10):e1005177
pubmed: 26485519
Biochim Biophys Acta. 2016 Feb;1863(2):303-13
pubmed: 26592459
Cell Syst. 2015 Dec 23;1(6):417-425
pubmed: 26771021
Cell Rep. 2016 Feb 9;14(5):1218-1231
pubmed: 26832412
Trends Immunol. 2016 Jul;37(7):427-439
pubmed: 27236363
Nat Cell Biol. 2016 Aug;18(8):851-63
pubmed: 27398911
Clin Cancer Res. 2017 May 15;23(10):2565-2574
pubmed: 27815356
J Immunol. 2017 Jan 15;198(2):657-668
pubmed: 27940659
Mol Cancer Ther. 2017 Apr;16(4):671-680
pubmed: 28138031
Oncotarget. 2017 Jul 11;8(28):45459-45469
pubmed: 28525372
Adv Genet. 1979;20:357-459
pubmed: 390999
Blood. 1995 Dec 1;86(11):4199-205
pubmed: 7492778
Nature. 1995 Dec 14;378(6558):736-9
pubmed: 7501023
Cancer Res. 1994 Jun 1;54(11):3049-53
pubmed: 7514496
Blood. 1994 Nov 15;84(10):3465-72
pubmed: 7524740
J Biol Chem. 1994 Dec 16;269(50):31991-8
pubmed: 7527401
J Urol. 1995 Feb;153(2):511-5
pubmed: 7529338
Blood. 1995 Feb 1;85(3):641-9
pubmed: 7530502
Immunity. 1994 Dec;1(9):733-9
pubmed: 7534619
Immunity. 1995 Sep;3(3):313-9
pubmed: 7552996
Am J Pathol. 1995 Sep;147(3):815-22
pubmed: 7677193
Blood. 1993 Aug 15;82(4):1151-8
pubmed: 7688988
Cancer Res. 1996 Jan 15;56(2):370-6
pubmed: 8542594
Blood. 1996 Nov 15;88(10):3887-93
pubmed: 8916954
Oncogene. 1996 Dec 5;13(11):2339-47
pubmed: 8957075
Blood. 1997 Aug 15;90(4):1345-64
pubmed: 9269751
Gastroenterology. 1997 Dec;113(6):1906-15
pubmed: 9394730
J Exp Med. 1998 May 4;187(9):1395-402
pubmed: 9565632
Methods Cell Biol. 1998;57:265-78
pubmed: 9648110
J Pathol. 1998 Sep;186(1):59-66
pubmed: 9875141